Treatment of mucosal leishmaniasis in Latin America: systematic review.
about
Population structure and evidence for both clonality and recombination among Brazilian strains of the subgenus Leishmania (Viannia)Chemotherapeutic potential of 17-AAG against cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensisVoice disorders in mucosal leishmaniasisDETC induces Leishmania parasite killing in human in vitro and murine in vivo models: a promising therapeutic alternative in Leishmaniasis.Potential Challenges of Controlling Leishmaniasis in Sri Lanka at a Disease Outbreak.Cutaneous Manifestations of Human and Murine LeishmaniasisReactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.Mucosal Leishmaniasis caused by Leishmania (Viannia) braziliensis and Leishmania (Viannia) guyanensis in the Brazilian Amazon.The impact of human immunodeficiency virus (HIV) co-infection on the economic burden of cutaneous leishmaniasis (CL) in Brazil and potential value of new CL drug treatmentsAn update on pharmacotherapy for leishmaniasisThe involvement of TLR2 and TLR4 in cytokine and nitric oxide production in visceral leishmaniasis patients before and after treatment with anti-leishmanial drugs.Can we use a lower dose of liposomal amphotericin B for the treatment of mucosal American leishmaniasis?Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective StudyAssociation of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.Lip leishmaniasis: Clinical characteristics of 621 patients.Liposomal amphotericin B as a treatment for human leishmaniasisToll-like receptors and leishmaniasis.The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas.Reactivation of cutaneous and mucocutaneous tegumentary leishmaniasis in rheumatoid arthritis patients: an emerging problem?Endemic tegumentary leishmaniasis in Brazil: correlation between level of endemicity and number of cases of mucosal diseaseThe Economic Impact of Cutaneous Leishmaniasis in Sri LankaLiposomes can both enhance or reduce drugs penetration through the skin
P2860
Q27305044-1DFECB09-F8A9-4F7F-A601-E6177015EFFDQ28544030-7C4E7D3E-31AC-47EF-A7EE-C6C261AD873CQ30434344-8B4E256E-787A-4782-9629-A3E4B850030AQ33784195-CB504529-C5C5-4F9C-AA85-1E7DFEA13808Q33786761-171172DA-776F-46C9-B260-F593C750D4D5Q33839048-FB272A12-80CF-41C4-9E83-C4BFC82E6F34Q33841162-96D14F41-8EF9-4AF6-8F00-BE86025FF46DQ33847397-A7BD3659-676E-4036-A7F1-BF967EC54770Q34138468-7010D455-F7A8-4C8D-B8F0-87285C325CA5Q34945204-254E8E9D-4F46-44CE-BEB9-876BDCCE9589Q35112512-8D46C4EA-F5B6-424B-A820-12E7E109195BQ35494361-A28850BD-5AFD-4DCB-A3D4-C1E0C1C81940Q36359258-D31B1C79-4BF3-4DBD-886D-741E756B2C2AQ36365284-93514B25-96AF-434B-93E3-EF8794E40DA0Q36443012-0C68D0AD-4DD8-445B-AD9A-A4BC93DDFB82Q36456032-C093918E-BDB5-4C71-8027-AE8BCF808C32Q36483521-4DB73266-F4C3-4913-99C8-DBE7F2595C04Q37147622-99C9DB2B-22C9-43E5-AD49-86729A881CE9Q42347671-A0B25D80-61C4-49AC-8A35-C38CEAB84CDDQ42749352-03E0ECFE-7307-4B62-BC15-3B691C313502Q58571765-BA44FBF9-1AAF-4244-9CB1-BA57954EAB73Q58763362-EF7C1551-996F-4ED6-A223-34A784333051
P2860
Treatment of mucosal leishmaniasis in Latin America: systematic review.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@ast
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@en
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@nl
type
label
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@ast
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@en
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@nl
prefLabel
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@ast
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@en
Treatment of mucosal leishmaniasis in Latin America: systematic review.
@nl
P2093
P1476
Treatment of mucosal leishmaniasis in Latin America: systematic review
@en
P2093
Andre Machado Siqueira
Antonio Carlos Nicodemo
Felipe Francisco Tuon
Valdir Sabbaga Amato
Vicente Amato Neto
P304
P356
10.4269/AJTMH.2007.77.266
P407
P577
2007-08-01T00:00:00Z